StonvexLoading…
StonvexStonvexStonvexCore line items from MATX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $757.80M | $3.34B | $2.49B | $1.61B |
Operating Income | $61.40M | $499.80M | $356.10M | $195.10M |
Net Income | $56.60M | $444.80M | $301.70M | $94.70M |
EPS (Diluted) | $1.85 | $13.81 | $9.28 | $5.09 |
Total Assets | $4.58B | $4.64B | $4.60B | $4.48B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $100.10M | $141.90M | $92.70M | $59.10M |
Free Cash Flow OCF − CapEx | $45.70M | $153.70M | $111.50M | $19.10M |
Shares Outstanding | 30.60M | 30.40M | 32.50M | 32.80M |